Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H31N3O5.2H2O |
Molecular Weight | 441.5185 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O
InChI
InChIKey=CZRQXSDBMCMPNJ-ZUIPZQNBSA-N
InChI=1S/C21H31N3O5.2H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);2*1H2/t16-,17-,18-;;/m0../s1
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C21H31N3O5 |
Molecular Weight | 405.4879 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:48 UTC 2023
by
admin
on
Fri Dec 15 15:01:48 UTC 2023
|
Record UNII |
E7199S1YWR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548860
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
WHO-ATC |
C09BB03
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
WHO-VATC |
QC09BA03
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
481915
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
WHO-ATC |
C09BA03
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
WHO-ATC |
C09AA03
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
NCI_THESAURUS |
C247
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
WHO-ATC |
C10BX07
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
NDF-RT |
N0000175562
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
WHO-VATC |
QC09BB03
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
365512
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
||
|
WHO-VATC |
QC09AA03
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB02939MIG
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
E7199S1YWR
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
100000091631
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
758151
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
83915-83-7
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
Lisinopril
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL1237
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
C29159
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
U-48
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
751176
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
1587
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
6360
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
29046
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | RxNorm | ||
|
LISINOPRIL
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
5362118
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
m6842
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
6503
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
DTXSID2045600
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
D017706
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
1368609
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
DB00722
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY | |||
|
E7199S1YWR
Created by
admin on Fri Dec 15 15:01:48 UTC 2023 , Edited by admin on Fri Dec 15 15:01:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
PARENT -> SALT/SOLVATE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
ANHYDROUS->SOLVATE |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
ROUTE OF ADMINISTRATION |
|
||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
STAGE C REDUCED EJECTION FRACTION HEART FAILURE |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||